We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$390M
AUM Growth
+$46.9M
Cap. Flow
+$17M
Cap. Flow %
4.37%
Top 10 Hldgs %
58.21%
Holding
38
New
5
Increased
16
Reduced
11
Closed
5

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$12.6M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$9.53M
3
LLY icon
Eli Lilly
LLY
+$9.37M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$7.86M
5
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$6.66M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$10.9M
2
ILMN icon
Illumina
ILMN
+$9.8M
3
RMD icon
ResMed
RMD
+$6.4M
4
HSP
HOSPIRA INC
HSP
+$6.06M
5
SHPG
Shire pic
SHPG
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 76.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$36.5M 9.35%
724,347
+178,940
+33% +$9.37M
FRX
2
DELISTED
FOREST LABORATORIES INC
FRX
$34.5M 8.85%
805,700
-96,300
-11% -$4.18M
JNJ icon
3
Johnson & Johnson
JNJ
$609B
$31.6M 8.11%
364,800
-20,700
-5% -$1.86M
BSX icon
4
Boston Scientific
BSX
$65.4B
$30M 7.69%
2,551,800
-1,005,200
-28% -$10.9M
CAH icon
5
Cardinal Health
CAH
$53.5B
$20.4M 5.24%
391,800
-14,200
-3% -$721K
BAX icon
6
Baxter International
BAX
$11.7B
$20M 5.13%
560,400
+88,183
+19% +$3.42M
A icon
7
Agilent Technologies
A
$37.1B
$14.2M 3.65%
387,945
+181,041
+88% +$6.1M
AUXL
8
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$13.9M 3.56%
761,924
+77,200
+11% +$1.39M
CBST
9
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$13M 3.33%
204,042
-85,400
-30% -$5.16M
ONXX
10
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$12.9M 3.3%
103,215
-26,600
-20% -$3.37M
EW icon
11
Edwards Lifesciences
EW
$49.4B
$12.5M 3.22%
+1,080,000
New +$12.6M
MDCO
12
DELISTED
Medicines Co
MDCO
$10.7M 2.74%
318,350
+43,600
+16% +$1.39M
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
$10.4M 2.66%
+148,900
New +$9.53M
MASI
14
DELISTED
Masimo
MASI
$10M 2.57%
375,691
-10,300
-3% -$254K
RVTY icon
15
Revvity
RVTY
$12.3B
$9.96M 2.55%
263,700
+21,700
+9% +$779K
TEVA icon
16
Teva Pharmaceuticals
TEVA
$37.3B
$9.95M 2.55%
263,300
-75,700
-22% -$2.95M
SLXP
17
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$9.45M 2.42%
141,301
-5,700
-4% -$393K
LPNT
18
DELISTED
LifePoint Health, Inc.
LPNT
$8.74M 2.24%
187,400
+39,600
+27% +$1.9M
THOR
19
DELISTED
THORATEC CORPORATION
THOR
$8.58M 2.2%
230,000
+30,000
+15% +$1.05M
VRTX icon
20
Vertex Pharmaceuticals
VRTX
$123B
$8.02M 2.06%
105,800
+10,500
+11% +$836K
MNK
21
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$7.89M 2.02%
+179,000
New +$7.86M
ESRX
22
DELISTED
Express Scripts Holding Company
ESRX
$7.57M 1.94%
122,500
+9,500
+8% +$614K
VOLC
23
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$7.49M 1.92%
+312,700
New +$6.66M
BIO icon
24
Bio-Rad Laboratories Class A
BIO
$8.15B
$6.33M 1.62%
53,800
+16,800
+45% +$1.98M
AGN
25
DELISTED
Allergan Inc
AGN
$6.14M 1.58%
67,900
+24,900
+58% +$2.24M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2013 Portfolio in Review

As of Q3 2013, Sector Gamma AS held 38 positions worth $390M, up 14% from $343M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS deployed $17M of net new capital in Q3 2013, opening 5 new positions and adding to 16 existing holdings. Its largest new stake was Edwards Lifesciences: 1,080,000 shares worth $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 80% a quarter earlier.

On the sell side, the largest reduction was Boston Scientific, an estimated $10.9M trimmed.

  • Sector Gamma AS's largest Q3 2013 buy was Edwards Lifesciences: 1,080,000 shares worth $12.5M.
  • Sector Gamma AS added most to Eli Lilly in Q3 2013, an estimated $9.37M increase.
  • Sector Gamma AS's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $10.9M.
  • Sector Gamma AS fully exited Illumina in Q3 2013, selling an estimated $9.8M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $390M portfolio in Q3 2013.
  • Sector Gamma AS opened 5 new positions and closed 5 in Q3 2013.
  • Sector Gamma AS's portfolio value rose 14% quarter-over-quarter to $390M.

Based on Sector Gamma AS's 13F filing for Q3 2013, filed 16 Dec 2013.